Literature DB >> 6846134

Disopyramide-induced QT prolongation and ventricular tachyarrhythmias.

N Riccioni, M Castiglioni, C Bartolomei.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6846134     DOI： 10.1016/0002-8703(83)90259-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  6 in total

Review 1.  A prolonged QTc interval. Is it an important effect of antiarrhythmic drugs?

Authors:  F A Fish; D M Roden
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Nov-Dec

2.  Fatal torsade de pointes following jaundice in a patient treated with disopyramide.

Authors:  A Schattner; J Gindin; D Geltner
Journal:  Postgrad Med J       Date:  1989-05       Impact factor: 2.401

Review 3.  Is there an ideal antiarrhythmic drug? A review--with particular reference to class I antiarrhythmic agents.

Authors:  K A Muhiddin; P Turner
Journal:  Postgrad Med J       Date:  1985-08       Impact factor: 2.401

Review 4.  Drug interactions with cisapride: clinical implications.

Authors:  E L Michalets; C R Williams
Journal:  Clin Pharmacokinet       Date:  2000-07       Impact factor: 6.447

Review 5.  Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias.

Authors:  R N Brogden; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

Review 6.  Torsade de pointes. Mechanisms and management.

Authors:  C Napolitano; S G Priori; P J Schwartz
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.